Skip to Content
Morningstar

Fresenius Medical Care AG FME

Morningstar Rating
Unlock
Stock XETR Rating as of
€40.48 +0.08 (0.20%)
View Full Chart
As of Delayed Price Closed
Unlock our analysis with Morningstar Investor
Start Free Trial

Company Report

View Archive

Price vs Fair Value

View History
FME is trading at a 287% premium.
Price
€40.40
Fair Value
€34.00
Uncertainty
High
1-Star Price
€79.00
5-Star Price
€44.00
Economic Moat
Rxshsy
Capital Allocation
Ldzvm

Bulls Say, Bears Say

Bulls

Diversified by geography and business mix, Fresenius should be able to benefit from ongoing growth in treating ESRD patients worldwide once the pandemic recedes.

Bears

With virtually all of its U.S. service profits coming from commercial insurance, Fresenius' profits could contract in several potential policy scenarios.

Show More
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if FME is a good fit for your portfolio.
Get 7 Days Free

News

View All

Trading Information

Previous Close Price
€40.40
Day Range
€39.60–40.48
52-Week Range
€30.16–49.62
Bid/Ask
€0.00 / €40.48
Market Cap
€11.88 Bil
Volume/Avg
523,781 / 474,255

Key Statistics

Price/Earnings (Normalized)
23.33
Price/Sales
0.61
Dividend Yield (Trailing)
2.99%
Dividend Yield (Forward)
3.18%
Total Yield
2.77%

Company Profile

Fresenius Medical Care is the largest dialysis company in the world, treating about 345,000 patients from over 4,100 clinics across the globe as of December 2022. In addition to providing dialysis services, the firm is a leading supplier of dialysis products, including machines, dialyzers, and concentrates. Fresenius accounts for about 35% of the global dialysis products market and benefits from being the world's only fully integrated dialysis business. Services account for roughly 80% of firmwide revenue, including care coordination and ancillary operations, while products account for the other roughly 20%. Products typically enjoy a higher margin, making them a strong contributor to the bottom line.
Sector
Healthcare
Industry
Medical Care Facilities
Stock Style Box
Mid Core
Total Number of Employees
119,845
Website
https://www.freseniusmedicalcare.com

Competitors

Valuation

View More
Metric
FME
FRE
DVA
Price/Earnings (Normalized)
 23.336.3214.98
Price/Book Value
 0.850.8313.02
Price/Sales
 0.610.711.03
Price/Cash Flow
 5.379.366.40
Price/Earnings
FME
FRE
DVA

Financial Strength

Metric
FME
FRE
DVA
Quick Ratio
 0.880.641.06
Current Ratio
 1.501.341.19
Interest Coverage
 3.122.123.95
Quick Ratio
FME
FRE
DVA

Profitability

Metric
FME
FRE
DVA
Return on Assets (Normalized)
 2.84%2.15%6.99%
Return on Equity (Normalized)
 7.19%7.52%118.17%
Return on Invested Capital (Normalized)
 4.44%3.57%10.75%
Return on Assets
FME
FRE
DVA
See how this stock stacks up to its competitors with Morningstar Investor
Start Free Trial

Medical Care Facilities Industry Comparables

Screen in Investor
Ticker
Name
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
HCA
HCA Healthcare IncYmjhlbyCnfghgq$85.6 Bil
FSNUY
Fresenius SE & Co KGaA ADR—Mtbnwf$17.1 Bil
FSNUF
Fresenius SE & Co KGaA—Fcmzcz$17.0 Bil
BDUUY
Bangkok Dusit Medical Services PCL ADR—Fgyx$12.6 Bil
BDUUF
Bangkok Dusit Medical Services PCL Units Non-Voting Depository Receipt—Jxwb$12.6 Bil
THC
Tenet Healthcare CorpPdcjzgbbMdkb$12.4 Bil
FMCQF
Fresenius Medical Care AG—Ngnxm$12.2 Bil
FMS
Fresenius Medical Care AG ADRVxxdHcrvqv$12.2 Bil
DVA
DaVita IncKdtkghtzyVclhyl$11.9 Bil
AMN
AMN Healthcare Services IncJkzgkcwYqbndd$2.1 Bil

Sponsor Center